CFFT Activities Transferred to the CF Foundation

This week, Congress approved a budget resolution that will allow lawmakers to make certain changes to the Affordable Care Act and Medicaid.

| 1 min read

Over the course of 2018, we will be transferring the activities of Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) to the CF Foundation. As our nonprofit drug discovery and development affiliate, CFFT was already controlled by the Foundation. Therefore, this transfer merely reflects a shift in the formal organizational structure to reduce potential confusion by the CF community and simplify administration, enabling us to operate optimally to achieve our mission.

Learn about the cutting-edge research conducted at the Cystic Fibrosis Foundation Therapeutics Lab, dedicated to advancing new therapies for everyone with cystic fibrosis, as well as the extensive range of research that the Foundation supports.

Share this article
Topics
Our Research Approach
Recent news
FDA Approves Orkambi for Children With CF Ages 1 to 2 Years
News | 3 min read
CF Foundation Joins More Than 2,000 CEOs in Commitment to Advance Diversity and Inclusion in the Workplace
News | 3 min read
CF Foundation Celebrates Passage of the Inflation Reduction Act
News | 3 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe